Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Endogenous galactose formation in galactose-1-phosphate uridyltransferase deficiency.

Schadewaldt P, Kamalanathan L, Hammen HW, Kotzka J, Wendel U.

Arch Physiol Biochem. 2014 Dec;120(5):228-39. doi: 10.3109/13813455.2014.962547. Epub 2014 Sep 30.

PMID:
25268296
2.

Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with >100 U insulin per day.

Kempf K, Schloot NC, Gärtner B, Keil R, Schadewaldt P, Martin S.

J Hum Nutr Diet. 2014 Apr;27 Suppl 2:21-7. doi: 10.1111/jhn.12145. Epub 2013 Aug 2.

PMID:
23909831
3.

Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans.

Nowotny B, Zahiragic L, Krog D, Nowotny PJ, Herder C, Carstensen M, Yoshimura T, Szendroedi J, Phielix E, Schadewaldt P, Schloot NC, Shulman GI, Roden M.

Diabetes. 2013 Jul;62(7):2240-8. doi: 10.2337/db12-1179. Epub 2013 Mar 1.

4.

Indirect calorimetry in humans: a postcalorimetric evaluation procedure for correction of metabolic monitor variability.

Schadewaldt P, Nowotny B, Strassburger K, Kotzka J, Roden M.

Am J Clin Nutr. 2013 Apr;97(4):763-73. doi: 10.3945/ajcn.112.035014. Epub 2013 Feb 27.

PMID:
23446893
5.

Differential glycomics of epithelial membrane glycoproteins from urinary exovesicles reveals shifts toward complex-type N-glycosylation in classical galactosemia.

Staubach S, Schadewaldt P, Wendel U, Nohroudi K, Hanisch FG.

J Proteome Res. 2012 Feb 3;11(2):906-16. doi: 10.1021/pr200711w. Epub 2011 Dec 2.

PMID:
22087537
6.

Features and outcome of galactokinase deficiency in children diagnosed by newborn screening.

Hennermann JB, Schadewaldt P, Vetter B, Shin YS, Mönch E, Klein J.

J Inherit Metab Dis. 2011 Apr;34(2):399-407. doi: 10.1007/s10545-010-9270-8. Epub 2011 Feb 3.

PMID:
21290184
7.

Longitudinal assessment of intellectual achievement in patients with classical galactosemia.

Schadewaldt P, Hoffmann B, Hammen HW, Kamp G, Schweitzer-Krantz S, Wendel U.

Pediatrics. 2010 Feb;125(2):e374-81. doi: 10.1542/peds.2008-3325. Epub 2010 Jan 25.

PMID:
20100763
8.

Urinary excretion of pentose phosphate pathway-associated polyols in early postnatal life.

Koy A, Waldhaus A, Hammen HW, Wendel U, Mayatepek E, Schadewaldt P.

Neonatology. 2009;95(3):256-61. doi: 10.1159/000167789. Epub 2008 Nov 5.

PMID:
18987485
9.

Biochemical monitoring of pregnancy and breast feeding in five patients with classical galactosaemia--and review of the literature.

Schadewaldt P, Hammen HW, Kamalanathan L, Wendel U, Schwarz M, Bosch AM, Guion N, Janssen M, Boers GH.

Eur J Pediatr. 2009 Jun;168(6):721-9. doi: 10.1007/s00431-008-0832-9. Epub 2008 Sep 24.

PMID:
18813948
10.

Description of the mutations in 15 subjects with variant forms of maple syrup urine disease.

Flaschker N, Feyen O, Fend S, Simon E, Schadewaldt P, Wendel U.

J Inherit Metab Dis. 2007 Nov;30(6):903-9. Epub 2007 Oct 8.

PMID:
17922217
11.

Urinary excretion of the nitrotyrosine metabolite 3-nitro-4-hydroxyphenylacetic acid in preterm and term infants.

Hoehn T, Janssen S, Mani AR, Brauers G, Moore KP, Schadewaldt P, Mayatepek E.

Neonatology. 2008;93(2):73-6. Epub 2007 Aug 6.

PMID:
17684421
12.

Variant maple syrup urine disease (MSUD)--the entire spectrum.

Simon E, Flaschker N, Schadewaldt P, Langenbeck U, Wendel U.

J Inherit Metab Dis. 2006 Dec;29(6):716-24. Epub 2006 Oct 25.

PMID:
17063375
13.

Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD.

Hoffmann B, Helbling C, Schadewaldt P, Wendel U.

Pediatr Res. 2006 Jan;59(1):17-20. Epub 2005 Dec 2.

PMID:
16326996
14.

Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany.

Simon E, Wendel U, Schadewaldt P.

Turk J Pediatr. 2005 Jan-Mar;47(1):8-13.

PMID:
15884622
15.

Neonatal screening, clinical features and genetic testing for galactosemia.

Zaffanello M, Zamboni G, Schadewaldt P, Borgiani P, Novelli G.

Genet Med. 2005 Mar;7(3):211-2. No abstract available.

PMID:
15775761
16.

Galactonate determination in urine by stable isotope dilution gas chromatography-mass spectrometry.

Schadewaldt P, Hammen HW, Stolpmann S, Kamalanathan L, Wendel U.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Mar 5;801(2):249-55.

PMID:
14751793
17.

Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients.

Schadewaldt P, Kamalanathan L, Hammen HW, Wendel U.

Mol Genet Metab. 2004 Jan;81(1):31-44.

PMID:
14728989
18.

Stable-isotope dilution analysis of galactose metabolites in human erythrocytes.

Schadewaldt P, Kamalanathan L, Hammen HW, Wendel U.

Rapid Commun Mass Spectrom. 2003;17(24):2833-8.

PMID:
14673834
19.

Renal excretion of galactose and galactitol in patients with classical galactosaemia, obligate heterozygous parents and healthy subjects.

Schadewaldt P, Killius S, Kamalanathan L, Hammen HW, Strassburger K, Wendel U.

J Inherit Metab Dis. 2003;26(5):459-79.

PMID:
14518827
20.

Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease.

Henneke M, Flaschker N, Helbling C, Müller M, Schadewaldt P, Gärtner J, Wendel U.

Hum Mutat. 2003 Nov;22(5):417.

PMID:
14517957

Supplemental Content

Loading ...
Support Center